{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:53:16Z","timestamp":1793145196270,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901878"],"award-info":[{"award-number":["81901878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1804183"],"award-info":[{"award-number":["U1804183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M662553"],"award-info":[{"award-number":["2019M662553"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020T130611"],"award-info":[{"award-number":["2020T130611"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009101","name":"Education Department of Henan Province","doi-asserted-by":"publisher","award":["20HASTIT049"],"award-info":[{"award-number":["20HASTIT049"]}],"id":[{"id":"10.13039\/501100009101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jconrel.2022.11.011","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T12:28:30Z","timestamp":1668428910000},"page":"909-919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress"],"prefix":"10.1016","volume":"352","author":[{"given":"Hongjuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.11.011_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100949","article-title":"Epigenetic remodeling hydrogel patches for multidrug-resistant triple-negative breast cancer","volume":"33","author":"Ji","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ccell.2018.11.016","article-title":"Tinagl1 suppresses triple-negative breast cancer progression and metastasis by simultaneously inhibiting integrin\/FAK and EGFR signaling","volume":"35","author":"Shen","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0015","doi-asserted-by":"crossref","first-page":"1703303","DOI":"10.1002\/adfm.201703303","article-title":"Nutlin-3a and cytokine co-loaded spermine-modified acetalated dextran nanoparticles for cancer chemo-immunotherapy","volume":"27","author":"Bauleth-Ramos","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904997","article-title":"Tumor-targeted drug and CpG delivery system for phototherapy and docetaxel-enhanced immunotherapy with polarization toward M1-type macrophages on triple negative breast cancers","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0025","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0030","article-title":"Glutathione-depleting organic metal adjuvants for effective NIR-II photothermal immunotherapy","volume":"34","author":"Chen","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0035","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","author":"Liu","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mattod.2021.08.002","article-title":"Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer","volume":"50","author":"Mu","year":"2021","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0045","first-page":"300","article-title":"Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy","volume":"17","author":"Han","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.actbio.2021.01.041","article-title":"An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway","volume":"124","author":"Ren","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0055","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/med.21765","article-title":"Understanding the tumor microenvironment for effective immunotherapy","volume":"41","author":"Sadeghi Rad","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0060","article-title":"Nanomedicine-boosting tumor immunogenicity for enhanced immunotherapy","volume":"2011171","author":"Huang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Martinez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semcancer.2018.11.003","article-title":"The roles of sirtuins family in cell metabolism during tumor development","volume":"57","author":"Zhu","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904639","article-title":"Intra\/extracellular lactic acid exhaustion for synergistic metabolic therapy and immunotherapy of tumors","volume":"31","author":"Gao","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0090","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.apsb.2022.02.014","article-title":"Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0095","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.7150\/thno.56747","article-title":"The double-edged roles of ROS in cancer prevention and therapy","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0100","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive oxygen species (ROS)-based nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214087","article-title":"Advances and perspectives in organic sonosensitizers for sonodynamic therapy","volume":"445","author":"Xing","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214267","article-title":"Recent advances on endogenous\/exogenous stimuli-triggered nanoplatforms for enhanced chemodynamic therapy","volume":"451","author":"Sun","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0115","doi-asserted-by":"crossref","first-page":"1580967","DOI":"10.1155\/2016\/1580967","article-title":"Reactive oxygen species regulate T cell immune response in the tumor microenvironment","volume":"2016","author":"Chen","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0120","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1172\/JCI122899","article-title":"Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease","volume":"129","author":"Sofi","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101891","article-title":"Immune cell - produced ROS and their impact on tumor growth and metastasis","volume":"42","author":"Kennel","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-19-0507","article-title":"Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma","volume":"8","author":"Xiang","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2011.03.001","article-title":"SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF","volume":"19","author":"Schumacker","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-4598-8-32","article-title":"The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells","volume":"8","author":"Shi","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.11.001","article-title":"Modulating ROS to overcome multidrug resistance in cancer","volume":"41","author":"Cui","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0155","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1093\/annonc\/mdz100.043","article-title":"Predictive role of derived neutrophil to lymphocyte ratio on platinum-based chemotherapy in triple-negative breast cancer","volume":"30","author":"Marra","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cac2.12031","article-title":"rs11046147 mutation in the promoter region of lactate dehydrogenase-B as a potential predictor of prognosis in triple-negative breast cancer","volume":"40","author":"Liu","year":"2020","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0165","doi-asserted-by":"crossref","first-page":"2002746","DOI":"10.1002\/advs.202002746","article-title":"Regulating glucose metabolism with prodrug nanoparticles for promoting photoimmunotherapy of pancreatic cancer","volume":"8","author":"Sun","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0170","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1158\/1078-0432.CCR-15-2274","article-title":"Myc-driven glycolysis is a therapeutic target in glioblastoma","volume":"22","author":"Tateishi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46315","article-title":"A positive feedback loop between Myc and aerobic glycolysis sustains tumor growth in a Drosophila tumor model","volume":"8","author":"Wong","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0180","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41585-019-0154-x","article-title":"Epigenetic drugs and their molecular targets in testicular germ cell tumours","volume":"16","author":"Jostes","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.phrs.2017.11.015","article-title":"Targeting bromodomain and extraterminal proteins in breast cancer","volume":"129","author":"Sahni","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0195","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.celrep.2016.08.032","article-title":"BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0200","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cclet.2020.11.006","article-title":"The progress and perspective of strategies to improve tumor penetration of nanomedicines","volume":"32","author":"Hu","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0205","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.apsb.2019.06.004","article-title":"Development and application of hyaluronic acid in tumor targeting drug delivery","volume":"9","author":"Luo","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/acs.nanolett.9b04012","article-title":"Sheddable prodrug vesicles combating adaptive immune resistance for improved photodynamic immunotherapy of cancer","volume":"20","author":"Gao","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101025","article-title":"Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer","volume":"36","author":"Zhou","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201870173","article-title":"Personalized cancer immunotherapy via transporting endogenous tumor antigens to lymph nodes mediated by nano Fe3 O4","volume":"14","author":"Wang","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0225","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1021\/acsnano.9b03288","article-title":"Amplified cancer immunotherapy of a surface-engineered antigenic microparticle vaccine by synergistically modulating tumor microenvironment","volume":"13","author":"Zhao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0230","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-020-00658-y","article-title":"The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses","volume":"28","author":"Aaes","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0235","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001388","article-title":"MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination","volume":"9","author":"Wu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0245","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s40425-019-0758-y","article-title":"Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition","volume":"7","author":"Mao","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0250","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/2159-8290.CD-20-0402","article-title":"Pharmacologic suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers","volume":"10","author":"Song","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101163","article-title":"Nanomedicines modulating myeloid-derived suppressor cells for improving cancer immunotherapy","volume":"39","author":"Dai","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2022.11.011_bb0260","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.semcancer.2020.03.015","article-title":"Nanoparticle mediated cancer immunotherapy","volume":"69","author":"Gupta","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2022.11.011_bb0265","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922007556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922007556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:41:54Z","timestamp":1759164114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922007556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":53,"alternative-id":["S0168365922007556"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}